Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
about
Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipidsPyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration.COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection.Determination of the Pharmacokinetics and Oral Bioavailability of Salicylamine, a Potent γ-Ketoaldehyde Scavenger, by LC/MS/MS.Isolevuglandin adducts in diseaseCyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy.Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.Scavengers of reactive γ-ketoaldehydes extend Caenorhabditis elegans lifespan and healthspan through protein-level interactions with SIR-2.1 and ETS-7.Molecular Structures of Isolevuglandin-Protein Cross-Links.Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.
P2860
Q28389004-930EC3BB-F380-49E3-BC96-DFDA00818600Q30358840-4C795025-FF9C-4409-9227-0A82947D5177Q34119479-A0A62C67-5B1D-4F8F-AE87-A66F46D56165Q34732834-E414EF44-9B4F-4B23-887C-D4DB249FD176Q35148031-25DF7979-8AAD-441E-B4AA-7BF8A2644414Q35794678-C4C955EB-2EFC-427E-AA8B-E4DD6E67BFE2Q36067379-C226DE17-8AD8-403F-88E1-23C885B5BA01Q36357707-48502522-DC3E-4ACB-91DE-67A2370AF391Q36653830-CAF1B7CB-5425-4A0C-8C8F-35C2E83139DEQ37312724-F6BCB65A-E910-43AB-A9A1-9954FFEE34A4Q37438010-F92328D7-085D-4FD7-9866-3B3294A1B7B3Q39499402-B4574D2D-2A72-4A7F-9775-483EE2A6AE06Q42214486-C05B47E3-D360-4CCB-8CF7-48DF7D53AAECQ48239770-C05520E2-903C-41C4-A942-1E9D9E394C4CQ51741486-D470990D-2AD8-4E17-8449-483D2DAC3D38
P2860
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@ast
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@en
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@nl
type
label
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@ast
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@en
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@nl
prefLabel
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@ast
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@en
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@nl
P2093
P3181
P1476
Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
@en
P2093
J W Schmidley
R G Salomon
P304
P3181
P356
10.1016/0952-3278(92)90145-9
P407
P577
1992-10-01T00:00:00Z